These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1419814

  • 21. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR, Chang Y, Ruan GR, Qin YZ, Lai YY, Shi HX, Wang YZ, Li LD, Jiang B, Li JL.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [Abstract] [Full Text] [Related]

  • 22. Minimally differentiated acute myeloid leukemia (AML M0): clinico-biological findings of 29 cases.
    Cascavilla N, Melillo L, D'Arena G, Greco MM, Carella AM, Sajeva MR, Perla G, Matera R, Minervini MM, Carotenuto M.
    Leuk Lymphoma; 2000 Mar; 37(1-2):105-13. PubMed ID: 10721774
    [Abstract] [Full Text] [Related]

  • 23. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ, Jacobs BC, Kappers-Klunne MC, Hählen K, Hooijkaas H, van Dongen JJ.
    Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
    [Abstract] [Full Text] [Related]

  • 24. [Cellular immunophenotypes in 97 adults with acute leukemia].
    Piedras J, López-Karpovitch X, Cárdenas MR.
    Rev Invest Clin; 1997 Mar; 49(6):457-64. PubMed ID: 9528305
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunoglobulin and T-cell receptor gene rearrangements in acute non-lymphocytic leukemias. Analysis of 54 cases and a review of the literature.
    Adriaansen HJ, Soeting PW, Wolvers-Tettero IL, van Dongen JJ.
    Leukemia; 1991 Sep; 5(9):744-51. PubMed ID: 1943227
    [Abstract] [Full Text] [Related]

  • 30. Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients.
    Casasnovas RO, Campos L, Mugneret F, Charrin C, Béné MC, Garand R, Favre M, Sartiaux C, Chaumarel I, Bernier M, Faure G, Solary E.
    Leukemia; 1998 Jan; 12(1):34-43. PubMed ID: 9436918
    [Abstract] [Full Text] [Related]

  • 31. Terminal transferase positive acute myeloid leukemia: immunophenotypic characterization and response to induction therapy.
    Lo Coco F, Lopez M, Pasqualetti D, Montefusco E, Cafolla A, Monarca B, Sgadari C, De Rossi G.
    Hematol Oncol; 1989 Jan; 7(2):167-74. PubMed ID: 2646199
    [Abstract] [Full Text] [Related]

  • 32. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
    Boeckx N, Willemse MJ, Szczepanski T, van der Velden VH, Langerak AW, Vandekerckhove P, van Dongen JJ.
    Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
    [Abstract] [Full Text] [Related]

  • 33. Surface marker analysis and karyotype distinguish acute biphenotypic leukemia from acute myelogenous leukemia expressing terminal deoxynucleotidyl transferase.
    Moscinski LC, Nowell PC, Hoxie JA, Berger MS, Prystowsky MB.
    Cancer; 1991 Nov 15; 68(10):2161-8. PubMed ID: 1913454
    [Abstract] [Full Text] [Related]

  • 34. High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase.
    Seremetis SV, Pelicci PG, Tabilio A, Ubriaco A, Grignani F, Cuttner J, Winchester RJ, Knowles DM, Dalla-Favera R.
    J Exp Med; 1987 Jun 01; 165(6):1703-12. PubMed ID: 3473183
    [Abstract] [Full Text] [Related]

  • 35. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.
    Drexler HG, Sperling C, Ludwig WD.
    Leukemia; 1993 Aug 01; 7(8):1142-50. PubMed ID: 7688837
    [Abstract] [Full Text] [Related]

  • 36. Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers.
    Norton JD, Campana D, Hoffbrand AV, Janossy G, Coustan-Smith E, Jani H, Yaxley JC, Prentice HG.
    Leukemia; 1987 Nov 01; 1(11):757-61. PubMed ID: 3500372
    [Abstract] [Full Text] [Related]

  • 37. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
    Lee EJ, Yang J, Leavitt RD, Testa JR, Civin CI, Forrest A, Schiffer CA.
    Leukemia; 1992 Nov 01; 6(11):1203-9. PubMed ID: 1279324
    [Abstract] [Full Text] [Related]

  • 38. Sterile transcription of immunoglobulin/T-cell receptor genes and other evidence of early lymphoid differentiation in acute myelogenous leukemia.
    Williams L, Moscinski LC.
    Leukemia; 1993 Sep 01; 7(9):1423-31. PubMed ID: 8371592
    [Abstract] [Full Text] [Related]

  • 39. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N, Musto P, D'Arena G, Melillo L, Carella AM, Petrilli MP, Sanpaolo G, Carotenuto M.
    Haematologica; 1998 May 01; 83(5):392-7. PubMed ID: 9658721
    [Abstract] [Full Text] [Related]

  • 40. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.
    Umiel T, Pattengale P, Weinberg K.
    Leukemia; 1993 Mar 01; 7(3):435-40. PubMed ID: 8445948
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.